In addition, the EAM group in “early” stages (3W) developed severe cardiac dysfunction (Figure 2), including decrease of EF and FS, ventricular dilation, and hypertrophy with reduced RIP1, RIP3, and MLKL expression. Here, MLKL is linked to cardiac hypertrophy.